PureTech Health PLC (LSE:PRTC) - Overview

Stock Report

PureTech Health PLC PRTC

Last Price
GBX126.50

Day Change
-1.63|-1.27%

As of 02/12/2016
16:35:18 GMT | GBX
Minimum 15 Minutes Delay.

Last Close128.13p
Day Range126.50 - 126.86
Mkt Cap300.30Mil
52-Wk Range118.00 - 172.00
Yield %0.00
ISINGB00BY2Z0H74
Volume3,849
P/E-8.92
P/S29.36
P/CF-12.14

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
PureTech Health PLC-6.30 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover5.461.357.98
Operating Profit-2.40-10.62-29.46
Net Profit-3.59-46.21-39.32
Reported EPS-1.34-11.14-14.18
Balance Sheet
Current Assets7.3642.87214.78
Non Current Assets2.812.775.77
Total Assets10.1745.64220.56
Current Liabilities13.8060.18108.35
Total Liabilities15.0460.61109.82
Total Equity-4.87-14.98110.73
Cash Flow
Operating Cash Flow-5.64-6.42-19.31
Net Change in Cash-2.3733.4249.33
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-66.23-24.40--5.18---
2017-77.65-28.62--4.42---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/07/2016Transfer inDr. Raju Kucherlapati0.00735,4520.00
28/04/2016PurchaseDame Marjorie Scardino135.005,0006,750.00

Company Profile

PureTech Health PLC is a cross-disciplinary healthcare company developing products that could improve the lives of patients.
 

Sector

Biotechnology

Market Position

548 of 1865 Companies

Index

FTSE Small Cap ,FTSE All Share

Outlook

(07/09/2016) ceo - "We look to the future with confidence"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-4.4716.2916.27
Div Yld (E)0.004.604.36
PEG (E)0.001.200.00
ROCE-33.6027.4680.66
Op Mrgn-470.14-17.19-14.86
EPS Grwth0.0016.0825.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy3
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Joichi Ito
Chief Executive OfficerMs. Daphne Zohar
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.